Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Standardization of postoperative adverse event reporting: A critical opportunity for improvement within the National Clinical Trials Network.
Journal: Cancer
Published: July 28, 2026
Equity and Automation in Clinical Trial Screening: Risks and Responsibilities of Artificial Intelligence‑Enabled Matching and Enrollment Systems.
Journal: JCO clinical cancer informatics
Published: July 07, 2026
Appendiceal Adenocarcinoma Cytoreduction Outcomes and Perioperative Serum Tumor Marker Levels.
Journal: JAMA network open
Published: May 04, 2026
KRAS inhibition is an effective therapy for appendiceal adenocarcinoma.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
Role of Palliative Cytoreductive Surgery for Patients with Incompletely Resectable Peritoneal Carcinomatosis from Lower Gastrointestinal Cancers.
Journal: Annals of surgical oncology
Published: April 10, 2026
Risk of Ovarian Metastasis in Colorectal Cancer-Related Carcinomatosis.
Journal: Annals of surgical oncology
Published: March 26, 2026
KRAS inhibition is an effective therapy for appendiceal adenocarcinoma.
Journal: Journal of hematology & oncology
Published: February 27, 2026
Proteomic and Lipidomic Atlas of Gut-Associated Lymph and Venous Depots in Female Piglets.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: January 22, 2026
ASO Visual Abstract: Clinicopathologic and Molecular Characteristics of High-Grade Appendiceal Mucinous Neoplasms.
Journal: Annals of surgical oncology
Published: December 09, 2025
ASO Author Reflections: An Evolving Understanding of High-Grade Appendiceal Mucinous Neoplasms.
Journal: Annals of surgical oncology
Published: November 04, 2025
Development and characterization of orthotopic patient-derived xenograft models of peritoneal metastatic mucinous appendiceal adenocarcinoma.
Journal: ESMO gastrointestinal oncology
Published: October 10, 2025
Outcomes following diagnostic laparoscopy in patients with peritoneal carcinomatosis deemed ineligible for cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) due to disease burden.
Journal: Surgical oncology insight
Published: July 31, 2025
Last Updated: 09/26/2026